Key result
MI in SLE patients shows no significant difference in ≥50% coronary atherosclerosis versus non-SLE controls.
Why the study?
Few studies have investigated the characteristics and risk factors of myocardial infarctions in patients with SLE to understand underlying mechanisms.
What are the characteristics and risk factors of myocardial infarction in patients with systemic lupus erythematosus compared to non-SLE patients with MI and SLE patients without MI?
Case-Control (n=102)
What are the characteristics and risk factors of myocardial infarction in patients with systemic lupus erythematosus compared to non-SLE patients with MI and SLE patients without MI?
Absolute Event Rate: 88% vs 66%
p-value: p=0.07
Myocardial infarctions in SLE patients are predominantly associated with coronary atherosclerosis and are frequently preceded by symptomatic vascular disease, highlighting the need for aggressive cardiovascular surveillance and atheroprotective treatment in this population.
Most SLE-related MIs involve atherosclerosis with prior vascular disease; supports vigilant CVD surveillance in SLE but leaves optimal prevention strategies open for prospective study.
OBJECTIVE: Patients with SLE have increased risk of myocardial infarction (MI). Few studies have investigated the characteristics of SLE-related MIs. We compared characteristics of and risk factors for MI between SLE patients with MI (MI-SLE), MI patients without SLE (MI-non-SLE) and SLE patients without MI (non-MI-SLE) to understand underlying mechanisms. METHODS: We identified patients with a first-time MI in the Karolinska SLE cohort. These patients were individually matched for age and gender with MI-non-SLE and non-MI-SLE controls in a ratio of 1:1:1. Retrospective medical file review was performed. Paired statistics were used as appropriate. RESULTS: Thirty-four MI-SLE patients (88% females) with a median age of 61 years were included. These patients had increased number of coronary arteries involved (p=0.04), and ≥50% coronary atherosclerosis/occlusion was numerically more common compared with MI-non-SLE controls (88% vs 66%; p=0.07). The left anterior descending artery was most commonly involved (73% vs 59%; p=0.11) and decreased (<50%) left ventricular ejection fraction occurred with similar frequency in MI-SLE and MI-non-SLE patients (45% vs 36%; p=0.79). Cardiovascular disease (44%, 5.9%, 12%; p<0.001) and coronary artery disease (32%, 2.9%, 0%; p<0.001), excluding MI, preceded MI/inclusion more commonly in MI-SLE than in MI-non-SLE and non-MI-SLE patients, respectively. MI-SLE patients had lower plasma albumin levels than non-MI-SLE patients (35 (29-37) vs 40 (37-42) g/L; p=0.002). CONCLUSION: In the great majority of cases, MIs in SLE are associated with coronary atherosclerosis. Furthermore, MIs in SLE are commonly preceded by symptomatic vascular disease, calling for attentive surveillance of cardiovascular disease and its risk factors and early atheroprotective treatment.
No takes yet. Share an insight, caveat, or question.
Samuelsson et al. (2021) conducted a case-control in Systemic lupus erythematosus and myocardial infarction (n=102). Systemic lupus erythematosus vs. Non-SLE patients with MI and SLE patients without MI was evaluated on ≥50% coronary atherosclerosis/occlusion (p=0.07). Myocardial infarction in SLE patients was associated with ≥50% coronary atherosclerosis/occlusion in 88% of cases compared to 66% in non-SLE MI controls (p=0.07).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: